微信公众号

官网二维码
中国癌症防治杂志

中国癌症防治杂志 ›› 2021, Vol. 13 ›› Issue (1): 56-61.doi: 10.3969/j.issn.1674-5671.2021.01.10

• 基础研究 • 上一篇    下一篇

miR-491-5p靶向FGFR4调节肝母细胞瘤细胞增殖和迁移

  

  1.  
  • 出版日期:2021-02-25 发布日期:2021-03-05
  • 通讯作者: 任慧 E-mail：Beatrice0800@163.com
  • 基金资助:
    河北省医学科学研究重点课题计划项目（20180045）

 miR-491-59 regulates the proliferation and migration of hepatoblastoma cells by targeting FGFR4

  1.  
  • Online:2021-02-25 Published:2021-03-05

PDF (PC)

61

赞

摘要： 目的 探讨miR-491-5p靶向调节FGFR4对肝母细胞瘤增殖和迁移的影响及可能的作用机制。方法 采用qRT-PCR检测15例小儿肝母细胞瘤组织及其癌旁正常组织，正常肝细胞LO2和肝母细胞瘤细胞HuH-6中miR-491-5p和FGFR4 mRNA的表达；Western blot检测FGFR4蛋白表达；TargetScan数据库预测miR-491-5p靶点；双荧光素酶报告基因实验检测miR-491-5p与FGFR4的靶向关系。将mimic NC、miR-491-5p mimic、pcDNA3.1和pcDNA3.1-FGFR4质粒分别转染至HuH-6细胞后，采用qRT-PCR与Western blot检测FGFR4的表达，CCK-8实验检测细胞增殖能力，Transwell小室实验检测细胞迁移能力，Western blot检测GSK3β/β-catenin信号通路相关蛋白的表达。结果 小儿肝母细胞瘤组织和HuH-6细胞中miR-491-5p表达水平均低于癌旁正常组织及肝细胞LO2（P<0.05），而FGFR4表达水平高于癌旁正常组织及肝细胞LO2（P<0.05）；TargetScan数据库预测显示miR-491-5p与FGFR4存在结合位点。与mimic NC组比较，过表达miR-491-5p可抑制FGFR4表达、HuH-6细胞增殖和迁移能力及p-GSK3β/GSK3β、p-β-catenin/β-catenin及p-C-myc/C-myc比值（均P<0.05）。与mimic+Pc组比较，过表达FGFR4可逆转过表达miR-491-5p对HuH-6细胞增殖、迁移及p-GSK3β/GSK3β、p-β-catenin/β-catenin和p-C-myc/C-myc比值的抑制作用（均P<0.05）。结论 miR-491-5p通过负向调控FGFR4抑制肝母细胞瘤细胞增殖和迁移，可能与GSK3β/β-catenin信号通路失活有关。

 

关键词: 肝母细胞瘤, miR-491-5p, FGFR4, GSK3β/β-catenin信号通路, 增殖, 迁移

Abstract: Objective To investigate the effect of miR-491-5p targeting and regulating FGFR4 on the proliferation and migration of hepatoblastoma and its possible mechanism. Methods The expressions of miR-491-5p and FGFR4 mRNA in 15 cases of pediatric hepatoblastoma tissues and adjacent normal tissues, the normal hepatocytes cells LO2 and hepatoblastoma cells HuH-6 were detected by qRT-PCR, and the expression level of FGFR4 protein was detected by Western blot. TargetScan database predicted the target of miR-491-5p, and the relationship between miR-491-5 and FGFR4 was detected by luciferase activity assay. After the mimic NC, miR-491-5p mimic, pcDNA3.1 plasmid and pcDNA3.1-FGFR4 plasmid were all transfected into HuH-6 cells, the expression of FGFR4 was detected by qRT-PCR and Western blot, the cells proliferation was detected by CCK-8, the cell migration assay was detected by Transwell assay, and the expression of GSK3β/β-catenin signaling pathway related proteins was detected by Western blot. Results The expression level of miR-491-5p in pediatric hepatoblastoma tissues and HuH-6 cells was lower than that in adjacent normal tissues and hepatocyte cells LO2(P<0.05), while the expression level of FGFR4 was higher than that in adjacent normal tissues and hepatocyte cells LO2(P<0.05). TargetScan database predicted that miR-491-5p and FGFR4 had binding sites. Compared with the mimic NC group, overexpression of miR-491-5p inhibited the expression of FGFR4, the proliferation and migration of hepatoblastoma cells HuH-6, and the ratios of p-GSK3β/GSK3β, p-β-catenin/β-catenin and p-C-myc/C-myc(all P<0.05). Compared with mimic+Pc group, overexpression of FGFR4 could reverse the inhibitory effect of miR-491-5p on the proliferation and migration of HuH-6 cells, and the ratio of p-GSK3β/GSK3β, p-β-catenin/β-catenin and p-C-myc/C-myc(all P<0.05). Conclusion miR-491-5p negatively regulates FGFR4 to inhibit the proliferation and migra-tion of hepatoblastoma cells, which may be related to the inactivation of GSK3β/β-catenin signaling pathway.

Key words: Hepatoblastoma cells, miR-491-5p, FGFR4, GSK3β/β-catenin signaling pathway, Proliferation, Migration  ,

中图分类号: 

  • R735.7